Platelet-rich plasma therapy - future or trend?

Arthritis Research and Therapy

Volumn 14, Issue 4, 2012, Pages

  Dhillon, Robinder S ^a   Schwarz, Edward M ^a   Maloney, Michael D ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; PLATELET DERIVED GROWTH FACTOR AB; PLATELET DERIVED GROWTH FACTOR BB; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA; SIGNAL PEPTIDE;

ACHILLES TENDON RUPTURE; ANTERIOR CRUCIATE LIGAMENT INJURY; ARTHROPLASTY; BIOLOGICAL THERAPY; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; DISTRACTION OSTEOGENESIS; DOPING; EPICONDYLITIS; ERYTHROCYTE; FRACTURE HEALING; HEALTH INSURANCE; HUMAN; IN VITRO STUDY; MEDICAL RESEARCH; MUSCLE REGENERATION; MUSCULOSKELETAL INJURY; NONHUMAN; OSSIFICATION; OSTEOARTHRITIS; PATIENT SAFETY; PROTEIN FUNCTION; REVIEW; ROTATOR CUFF INJURY; TENDON INJURY; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE RICH PLASMA; WOUND HEALING; ANIMAL; BLOOD; BLOOD COMPONENT THERAPY; FORECASTING; MUSCULOSKELETAL DISEASES; PHYSIOLOGY; PROCEDURES; TRENDS;

ANIMALS; BLOOD COMPONENT TRANSFUSION; FORECASTING; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MUSCULOSKELETAL DISEASES; PLATELET-RICH PLASMA; WOUND HEALING;

EID: 84865129719     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3914     Document Type: Review

References (78)

1. Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP?. Implant Dent 2001, 10:225-228. 10.1097/00008505-200110000-00002, 11813662.
2. Schwarz A. A Promising Treatment for Athletes, in Blood 2009, The New York Times., http://www.nytimes.com/2009/02/17/sports/17blood.html
3. Platelet Rich Plasma: a Market Snapshot. , http://www.docstoc.com/docs/47503668/Platelet-Rich-Plasma-A-Market-Snapshot
4. March L, Woolf AD. The global burden of musculoskeletal conditions - why is it important?. Best Pract Res Clin Rheumatol 2010, 24:721. 10.1016/j.berh.2011.01.001, 21665120.
5. Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ 2003, 81:646-656. 2572542, 14710506.
6. Banfi G, Corsi MM, Volpi P. Could platelet rich plasma have effects on systemic circulating growth factors and cytokine release in orthopaedic applications?. Br J Sports Med 2006, 40:816. 10.1136/bjsm.2006.029934, 2465084, 16920768.
7. Praemer AF. Musculoskeletal Conditions in the United States 1999, Rosemont: American Academy of Orthopaedic Surgeons, 2.
8. Marx RE, Garg AK. Dental and Craniofacial Applications of Platelet-Rich Plasma 2005, Carol Stream: Quintessence Publishing Co., Inc..
9. Academy of Sciences, Paris: M. Donné on the Blood Globules. Prov Med Surg J (1840) 1842, 3:498-499. 2489499, 21379534.
10. Sampson S, Gerhardt M, Mandelbaum B. Platelet rich plasma injection grafts for musculoskeletal injuries: a review. Curr Rev Musculoskelet Med 2008, 1:165-174. 10.1007/s12178-008-9032-5, 2682411, 19468902.
11. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003, 83:835-870.
12. Anitua E, Sánchez M, Nurden AT, Nurden P, Orive G, Andía I. New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol 2006, 24:227-234. 10.1016/j.tibtech.2006.02.010, 16540193.
13. Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 2004, 62:489-496. 10.1016/j.joms.2003.12.003, 15085519.
14. Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte-and platelet-rich fibrin (L-PRF). Trends Biotechnol 2009, 27:158-167. 10.1016/j.tibtech.2008.11.009, 19187989.
15. Yu W, Wang J, Yin J. Platelet-rich plasma: a promising product for treatment of peripheral nerve regeneration after nerve injury. Int J Neurosci 2011, 121:176-180. 10.3109/00207454.2010.544432, 21244302.
16. Weibrich G, Kleis WK, Hafner G, Hitzler WE, Wagner W. Comparison of platelet, leukocyte, and growth factor levels in point-of-care platelet-enriched plasma, prepared using a modified Curasan kit, with preparations received from a local blood bank. Clin Oral Implants Res 2003, 14:357-162. 10.1034/j.1600-0501.2003.00810.x, 12755786.
17. Gonshor A. Technique for producing platelet-rich plasma and platelet concentrate: background and process. Int J Periodontics Restorative Dent 2002, 22:547-557.
18. Borrione P, Gianfrancesco AD, Pereira MT, Pigozzi F. Platelet-rich plasma in muscle healing. Am J Phys Med Rehabil 2010, 89:854-861. 10.1097/PHM.0b013e3181f1c1c7, 20855985.
19. Christgau M, Moder D, Hiller KA, Dada A, Schmitz G, Schmalz G. Growth factors and cytokines in autologous platelet concentrate and their correlation to periodontal regeneration outcomes. J Clin Periodontol 2006, 33:837-845. 10.1111/j.1600-051X.2006.00991.x, 17018133.
20. Sanchez AR, Sheridan PJ, Kupp LI. Is platelet-rich plasma the perfect enhancement factor? A current review. Int J Oral Maxillofac Implants 2003, 18:93-103.
21. Lyras DN, Kazakos K, Agrogiannis G, Verettas D, Kokka A, Kiziridis G, Chronopoulos E, Tryfonidis M. Experimental study of tendon healing early phase: is IGF-1 expression influenced by platelet rich plasma gel?. Orthop Traumatol Surg Res 2010, 96:381-387. 10.1016/j.otsr.2010.03.010, 20452307.
22. Zapf J, Waldvogel M, Froesch ER. Binding of nonsuppressible insulinlike activity to human serum. Evidence for a carrier protein. Arch Biochem Biophys 1975, 168:638-645. 10.1016/0003-9861(75)90296-9, 237487.
23. Rinderknecht E, Humbel RE. The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem 1978, 253:2769-2776.
24. Froesch ER, Schmid C, Schwander J, Zapf J. Actions of insulin-like growth factors. Annu Rev Physiol 1985, 47:443-467. 10.1146/annurev.ph.47.030185.002303, 2986538.
25. Hwang DL, Latus LJ, Lev-Ran A. Effects of platelet-contained growth factors (PDGF, EGF, IGF-I, and TGF-beta) on DNA synthesis in porcine aortic smooth muscle cells in culture. Exp Cell Res 1992, 200:358-360. 10.1016/0014-4827(92)90183-9, 1572403.
26. Spencer EM, Tokunaga A, Hunt TK. Insulin-like growth factor binding protein-3 is present in the alpha-granules of platelets. Endocrinology 1993, 132:996-1001. 10.1210/en.132.3.996, 7679986.
27. Weibrich G, Kleis WK, Hafner G. Growth factor levels in the platelet-rich plasma produced by 2 different methods: curasan-type PRP kit versus PCCS PRP system. Int J Oral Maxillofac Implants 2002, 17:184-190.
28. Frechette JP, Martineau I, Gagnon G. Platelet-rich plasmas: growth factor content and roles in wound healing. J Dent Res 2005, 84:434-439. 10.1177/154405910508400507, 15840779.
29. Schmidmaier G, Herrmann S, Green J, Weber T, Scharfenberger A, Haas NP, Wildemann B. Quantitative assessment of growth factors in reaming aspirate, iliac crest, and platelet preparation. Bone 2006, 39:1156-1163. 10.1016/j.bone.2006.05.023, 16863704.
30. Ferrari M, Zia S, Valbonesi M, Henriquet F, Venere G, Spagnolo S, Grasso MA, Panzani I. A new technique for hemodilution, preparation of autologous platelet-rich plasma and intraoperative blood salvage in cardiac surgery. Int J Artif Organs 1987, 10:47-50.
31. Storrs C. Is Platelet-Rich Plasma an Effective Healing Therapy?. Scientific American 2009, , http://www.scientificamerican.com/article.cfm?id=platelet-rich-plasma-therapy-dennis-cardone-sports-medicine-injury&page=2
32. Cieslik-Bielecka A, Bielecki T, Gazdzik TS, Arendt J, Król W, Szczepanski T. Autologous platelets and leukocytes can improve healing of infected high-energy soft tissue injury. Transfus Apher Sci 2009, 41:9-12. 10.1016/j.transci.2009.05.006, 19524487.
33. Sánchez M, Azofra J, Anitua E, Andía I, Padilla S, Santisteban J, Mujika I. Plasma rich in growth factors to treat an articular cartilage avulsion: a case report. Med Sci Sports Exerc 2003, 35:1648-1652. 10.1249/01.MSS.0000089344.44434.50, 14523300.
34. Tomoyasu A, Higashio K, Kanomata K, Goto M, Kodaira K, Serizawa H, Suda T, Nakamura A, Nojima J, Fukuda T, Katagiri T. Platelet-rich plasma stimulates osteoblastic differentiation in the presence of BMPs. Biochem Biophys Res Commun 2007, 361:62-67. 10.1016/j.bbrc.2007.06.142, 17632078.
35. Goldring SR, Goldring MB. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop Relat Res 2004, 427(Suppl):S27-36.
36. Anitua E, Sánchez M, Nurden AT, Zalduendo MM, de la Fuente M, Azofra J, Andía I. Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients. Rheumatology (Oxford) 2007, 46:1769-1772. 10.1093/rheumatology/kem234, 17942474.
37. Liu Y, Kalén A, Risto O, Wahlström O. Fibroblast proliferation due to exposure to a platelet concentrate in vitro is pH dependent. Wound Repair Regen 2002, 10:336-340. 10.1046/j.1524-475X.2002.10510.x, 12406171.
38. Packer DL, Dombi GW, Yu PY, Zidel P, Sullivan WG. An in vitro model of fibroblast activity and adhesion formation during flexor tendon healing. J Hand Surg Am 1994, 19:769-776. 10.1016/0363-5023(94)90181-3, 7806798.
39. Bernard-Beaubois K, Hecquet C, Houcine O, Hayem G, Adolphe M. Culture and characterization of juvenile rabbit tenocytes. Cell Biol Toxicol 1997, 13:103-113.
40. Schulze-Tanzil G, Mobasheri A, Clegg PD, Sendzik J, John T, Shakibaei M. Cultivation of human tenocytes in high-density culture. Histochem Cell Biol 2004, 122:219-228. 10.1007/s00418-004-0694-9, 15338228.
41. Anitua E, Andía I, Sanchez M, Azofra J, del Mar Zalduendo M, de la Fuente M, Nurden P, Nurden A. Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. J Orthop Res 2005, 23:281-286. 10.1016/j.orthres.2004.08.015, 15779147.
42. de Mos M, van der Windt AE, Jahr H, van Schie HT, Weinans H, Verhaar JA, van Osch GJ. Can platelet-rich plasma enhance tendon repair? A cell culture study. Am J Sports Med 2008, 36:1171-1178. 10.1177/0363546508314430, 18326832.
43. Ni M, Tang P, Wang Y, Li G. [Experimental study on promoting bone consolidation by using platelet-rich plasma and decalcified bone matrix during distraction osteogenesis]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2011, 25:661-667.
44. Hammond JW, Hinton RY, Curl LA, Muriel JM, Lovering RM. Use of autologous platelet-rich plasma to treat muscle strain injuries. Am J Sports Med 2009, 37:1135-1142. 10.1177/0363546508330974, 19282509.
45. Sun Y, Feng Y, Zhang CQ, Chen SB, Cheng XG. The regenerative effect of platelet-rich plasma on healing in large osteochondral defects. Int Orthop 2010, 34:589-597. 10.1007/s00264-009-0793-2, 2903145, 19434411.
46. Schnabel LV, Mohammed HO, Miller BJ, McDermott WG, Jacobson MS, Santangelo KS, Fortier LA. Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons. J Orthop Res 2007, 25:230-240. 10.1002/jor.20278, 17106885.
47. Lyras DN, Kazakos K, Verettas D, Polychronidis A, Tryfonidis M, Botaitis S, Agrogiannis G, Simopoulos C, Kokka A, Patsouris E. The influence of platelet-rich plasma on angiogenesis during the early phase of tendon healing. Foot Ankle Int 2009, 30:1101-1106. 10.3113/FAI.2009.1101, 19912722.
48. Lyras DN, Kazakos K, Verettas D, Botaitis S, Agrogiannis G, Kokka A, Pitiakoudis M, Kotzakaris A. The effect of platelet-rich plasma gel in the early phase of patellar tendon healing. Arch Orthop Trauma Surg 2009, 129:1577-1582. 10.1007/s00402-009-0935-4, 19621231.
49. Sheth U, Simunovic N, Klein G, Fu F, Einhorn TA, Schemitsch E, Ayeni OR, Bhandari M. Efficacy of autologous platelet-rich plasma use for orthopaedic indications: a meta-analysis. J Bone Joint Surg Am 2012, 94:298-307. 10.2106/JBJS.K.00154, 22241606.
50. Sánchez M, Anitua E, Azofra J, Andía I, Padilla S, Mujika I. Comparison of surgically repaired Achilles tendon tears using platelet-rich fibrin matrices. Am J Sports Med 2007, 35:245-251.
51. Schepull T, Kvist J, Norrman H, Trinks M, Berlin G, Aspenberg P. Autologous platelets have no effect on the healing of human achilles tendon ruptures: a randomized single-blind study. Am J Sports Med 2011, 39:38-47. 10.1177/0363546510383515, 21051425.
52. Filardo G, Presti ML, Kon E, Marcacci M. Nonoperative biological treatment approach for partial Achilles tendon lesion. Orthopedics 2010, 33:120-123. 10.3928/01477447-20100104-31, 20192152.
53. Vogrin M, Rupreht M, Dinevski D, Hašpl M, Kuhta M, Jevsek M, Knežević M, Rožman P. Effects of a platelet gel on early graft revascularization after anterior cruciate ligament reconstruction: a prospective, randomized, double-blind, clinical trial. Eur Surg Res 2010, 45:77-85. 10.1159/000318597, 20814217.
54. Vogrin M, Rupreht M, Crnjac A, Dinevski D, Krajnc Z, Recnik G. The effect of platelet-derived growth factors on knee stability after anterior cruciate ligament reconstruction: a prospective randomized clinical study. Wien Klin Wochenschr 2010, 122(Suppl 2):91-95.
55. Gardner MJ, Demetrakopoulos D, Klepchick PR, Mooar PA. The efficacy of autologous platelet gel in pain control and blood loss in total knee arthroplasty. An analysis of the haemoglobin, narcotic requirement and range of motion. Int Orthop 2007, 31:309-313. 10.1007/s00264-006-0174-z, 2267605, 16816947.
56. Everts PA, Devilee RJ, Brown Mahoney C, Eeftinck-Schattenkerk M, Box HA, Knape JT, van Zundert A. Platelet gel and fibrin sealant reduce allogeneic blood transfusions in total knee arthroplasty. Acta Anaesthesiol Scand 2006, 50:593-599. 10.1111/j.1399-6576.2006.001005.x, 16643230.
57. Gosens T, Peerbooms JC, van Laar W, den Oudsten BL. Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: a double-blind randomized controlled trial with 2-year follow-up. Am J Sports Med 2011, 39:1200-1208. 10.1177/0363546510397173, 21422467.
58. Hechtman KS, Uribe JW, Botto-vanDemden A, Kiebzak GM. Platelet-rich plasma injection reduces pain in patients with recalcitrant epicondylitis. Orthopedics 2011, 34:92.
59. Wang-Saegusa A, Cugat R, Ares O, Seijas R, Cuscó X, Garcia-Balletbó M. Infiltration of plasma rich in growth factors for osteoarthritis of the knee short-term effects on function and quality of life. Arch Orthop Trauma Surg 2011, 131:311-317. 10.1007/s00402-010-1167-3, 20714903.
60. Filardo G, Kon E, Buda R, Timoncini A, Di Martino A, Cenacchi A, Fornasari PM, Giannini S, Marcacci M. Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthrosc 2010, 19:528-535.
61. Randelli P, Arrigoni P, Ragone V, Aliprandi A, Cabitza P. Platelet rich plasma in arthroscopic rotator cuff repair: a prospective RCT study, 2-year follow-up. J Shoulder Elbow Surg 2011, 20:518-528. 10.1016/j.jse.2011.02.008, 21570659.
62. Castricini R, Longo UG, De Benedetto M, Panfoli N, Pirani P, Zini R, Maffulli N, Denaro V. Platelet-rich plasma augmentation for arthroscopic rotator cuff repair: a randomized controlled trial. Am J Sports Med 2011, 39:258-265. 10.1177/0363546510390780, 21160018.
63. Everts PA, Devilee RJ, Brown Mahoney C, van Erp A, Oosterbos CJ, Stellenboom M, Knape JT, van Zundert A. Exogenous application of platelet-leukocyte gel during open subacromial decompression contributes to improved patient outcome. A prospective randomized double-blind study. Eur Surg Res 2008, 40:203-210. 10.1159/000110862, 17998780.
64. Everts PA, Knape JT, Weibrich G, Schönberger JP, Hoffmann J, Overdevest EP, Box HA, van Zundert A. Platelet-rich plasma and platelet gel: a review. J Extra Corpor Technol 2006, 38:174-187.
65. Anitua E, Orive G. Short implants in maxillae and mandibles: a retrospective study with 1 to 8 years of follow-up. J Periodontol 2010, 81:819-826. 10.1902/jop.2010.090637, 20450361.
66. Anitua E, Orive G, Aguirre JJ, Ardanza B, Andía I. 5-year clinical experience with BTI dental implants: risk factors for implant failure. J Clin Periodontol 2008, 35:724-732. 10.1111/j.1600-051X.2008.01248.x, 18616758.
67. Spero JA. Bovine thrombin-induced inhibitor of factor V and bleeding risk in postoperative neurosurgical patients. Report of three cases. J Neurosurg 1993, 78:817-820. 10.3171/jns.1993.78.5.0817, 8468613.
68. Cmolik BL, Spero JA, Magovern GJ, Clark R. Redo cardiac surgery: late bleeding complications from topical thrombin-induced factor V deficiency. J Thorac Cardiovasc Surg 1993, 105:222-227. discussion 227-228.
69. Ortel TL, Mercer MC, Thames EH, Moore KD, Lawson JH. Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin. Ann Surg 2001, 233:88-96. 10.1097/00000658-200101000-00014, 1421171, 11141230.
70. World Anti-Doping Agency The World Anti-Doping Code. The 2010 Prohibited List. International Standard. World Anti-Doping Agency., http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/WADA_Prohibited_List_2010_EN.pdf
71. World Anti-Doping Agency The World Anti-Doping Code. The 2010 Prohibited List. International Standard. World Anti-Doping Agency., http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/To_be_effective/WADA_Prohibited_List_2011_EN.pdf
72. Wright-Carpenter T, Klein P, Schäferhoff P, Appell HJ, Mir LM, Wehling P. Treatment of muscle injuries by local administration of autologous conditioned serum: a pilot study on sportsmen with muscle strains. Int J Sports Med 2004, 25:588-593. 10.1055/s-2004-821304, 15532001.
73. Borselli C, Storrie H, Benesch-Lee F, Shvartsman D, Cezar C, Lichtman JW, Vandenburgh HH, Mooney DJ. Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors. Proc Natl Acad Sci USA 2010, 107:3287-3292. 10.1073/pnas.0903875106, 2840452, 19966309.
74. Daugherty K, Porucznik MA. Treating tendons, bones, and cartilage with PRP. , http://www.aaos.org/news/aaosnow/jul11/cover2.asp
75. Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med 2006, 34:1774-1778. 10.1177/0363546506288850, 16735582.
76. Porucznik MA. PRP an unproven option, agree forum experts. , http://www.aaos.org/news/aaosnow/mar11/cover1.asp
77. Eppley BL, Woodell JE, Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plastic Reconstruct Surg 2004, 114:1502-1508.
78. Engebretsen L, Steffen K, Alsousou J, Anitua E, Bachl N, Devilee R, Everts P, Hamilton B, Huard J, Jenoure P, Kelberine F, Kon E, Maffulli N, Matheson G, Mei-Dan O, Menetrey J, Philippon M, Randelli P, Schamasch P, Schwellnus M, Vernec A, Verrall G. IOC consensus paper on the use of platelet-rich plasma in sports medicine. Br J Sports Med 2010, 44:1072-1081. 10.1136/bjsm.2010.079822, 21106774.